药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chlormezanone
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Gaboxadol.
Chlormezanone
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Gaboxadol.
Chlormezanone
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Gaboxadol.
Chlormezanone
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Gaboxadol.
Chlormezanone
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Gaboxadol.
Chlormezanone
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Gaboxadol.
Chlormezanone
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Gaboxadol.
Chlormezanone
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Gaboxadol.
Chlormezanone
Cannabidiol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Gaboxadol.
Chlormezanone
Taranabant
The risk or severity of adverse effects can be increased when Taranabant is combined with Gaboxadol.
Chlormezanone
Rimonabant
The risk or severity of adverse effects can be increased when Rimonabant is combined with Gaboxadol.
Chlormezanone
SLV319
The risk or severity of adverse effects can be increased when SLV319 is combined with Gaboxadol.
Chlormezanone
PCS-499
Gaboxadol may increase the excretion rate of PCS-499 which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
8-chlorotheophylline
Gaboxadol may increase the excretion rate of 8-chlorotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
Furafylline
Gaboxadol may increase the excretion rate of Furafylline which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
Bromotheophylline
Gaboxadol may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
Bufylline
Gaboxadol may increase the excretion rate of Bufylline which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
Pentifylline
Gaboxadol may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
Etamiphylline
Gaboxadol may increase the excretion rate of Etamiphylline which could result in a lower serum level and potentially a reduction in efficacy.
Chlormezanone
Acefylline
Gaboxadol may increase the excretion rate of Acefylline which could result in a lower serum level and potentially a reduction in efficacy.